MYX vs NXN

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

48LOW

NXN

NEXSEN LTD FPO [NXN]

48LOW

Score Breakdown

MYX NXN
Technical
78
70
Catalyst
87
55
Sentiment
50
50
Fundamental
87
72
Momentum
27
44
Risk Gate
45
42

Key Metrics

MYX Metric NXN
$189.7MMarket Cap$34.0M
599KAvg Volume (20d)335K
+2.9%Short InterestN/A
$7.29552-Week High$0.315
$2.04052-Week Low$0.130
+3.8%Daily Change+6.2%
$2.335Entry Price$0.170
-20.6%ROEN/A
-20.4%Profit MarginN/A

Active Signals

MYX Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Volume surging at 2.8x normal while price climbs — real buying conviction behind this move
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.5x)
●EPS estimates revised upward (+10pts)

NXN Signals

●MACD momentum is picking up steam
●Volume surging at 2.2x normal while price climbs — real buying conviction behind this move
●On a tear — up 17.2% over the last 5 days
●Volatility is expanding fast — choppy price action, so buckle up
●Adequate cash runway (8 quarters)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)
●CANSLIM S: Tight float (35%)

Ask Scout AI to compare MYX and NXN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
MYX Full Analysis → NXN Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).